Joseph Piven, MD, the Thomas E. Castelloe Distinguished Professor of Psychiatry and Pediatrics and director of the Carolina Institute for Developmental Disabilities was given the award for his fundamental contributions…
Neurology, News, Psychiatry And Mental Health, Research, Vital Signs
Gaorav Gupta, MD, PhD, Misty Good, MD, MS, and Jason Stein, PhD, were selected as Yang Family Biomedical Scholars in the eighth installment of this annual School of Medicine award.
Led by UNC School of Medicine’s Weili Lin, PhD, researchers document cognitive milestones revealed in children from birth to toddlerhood in brain imaging study.
A new study, led by researchers at the UNC School of Medicine, highlights the latest statistics on gastrointestinal cancers, hospital admissions, liver transplants, and national funding support for gastrointestinal research.
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes,…
Cardiology and Heart Health, Diabetes, General Medicine, News, Research
A national multi-site clinical trial, co-led by researchers at the UNC School of Medicine, has found that therapeutic hypothermia may be harming preterm infants recovering from a specific type of…
Clinical Research, News, Pediatrics And Children's Health, Research
With a designation from the FDA, a device created and patented by Flavio Frohlich, PhD, professor of psychiatry at the UNC School of Medicine and member of the UNC Neuroscience…
News, Psychiatry And Mental Health, Technology and Innovation
Researchers have discovered that RNA in Zika virus can freeze itself in time to further its spread in the body, revolutionizing how researchers study disease-causing viruses.
Biochemistry, Immunology And Microbiology, News, Research, Virology
Researchers at the UNC School of Medicine have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.
Addiction, Diabetes, News, Research, School of Medicine, Vital Signs
